2013 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

June 2013 | 295 pages | ID: 2B62E3F8F32EN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

• Hospitals
• Commercial/Private Labs
• Blood Banks
• Physician Offices
• Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 295 pages and 67 tables

Contents

I. INTRODUCTION

II. HEPATITIS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
    Classification
    Transmission of Infection
    Occupational Hazards
    Acute Hepatitis
    Diagnosis of Acute Infection
    Chronic Hepatitis
    HCV and Other Chronic Liver Diseases
    Alcoholic Liver Disease
    Hepatitis B Coinfection
    Cirrhosis and Hepatocellular Carcinoma
    Diagnostic Tests
    Possible Indications for HCV RNA Testing
    Conclusions and Future Direction
E. Hepatitis D
    Historical Perspective
    Epidemiology
    HBV-HDV "Coinfection" vs. "Superinfection"
    Methods of Detecting HDV
    Prevention
F. Hepatitis E
    Background
    Prevalence of the Disease
    Diagnostic Tests
    Epidemiologic Serosurveys
    Serologic Cross-Reactivity
G. Hepatitis G
    Vaccines and Drugs
H. Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers

I. EMERGING DIAGNOSTIC TECHNOLOGIES

1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V, ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES